JPH0456804B2 - - Google Patents

Info

Publication number
JPH0456804B2
JPH0456804B2 JP59049321A JP4932184A JPH0456804B2 JP H0456804 B2 JPH0456804 B2 JP H0456804B2 JP 59049321 A JP59049321 A JP 59049321A JP 4932184 A JP4932184 A JP 4932184A JP H0456804 B2 JPH0456804 B2 JP H0456804B2
Authority
JP
Japan
Prior art keywords
dna
virus
20mer
rna
messenger rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59049321A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60193922A (ja
Inventor
Akira Kaji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP59049321A priority Critical patent/JPS60193922A/ja
Priority to NZ209840A priority patent/NZ209840A/xx
Priority to GB08425799A priority patent/GB2148302B/en
Priority to AU34239/84A priority patent/AU578625B2/en
Priority to SE8405133A priority patent/SE466482B/sv
Priority to US06/661,204 priority patent/US4689320A/en
Priority to LU85594A priority patent/LU85594A1/de
Priority to PH31340A priority patent/PH21629A/en
Priority to BE0/213837A priority patent/BE900827A/fr
Priority to DK493584A priority patent/DK168061B1/da
Priority to NL8403163A priority patent/NL8403163A/nl
Priority to AT0329284A priority patent/AT392081B/de
Priority to DE19843437852 priority patent/DE3437852A1/de
Priority to IT68021/84A priority patent/IT1179144B/it
Priority to FR8415930A priority patent/FR2553420B1/fr
Priority to DZ847306A priority patent/DZ691A1/fr
Priority to CH4975/84A priority patent/CH667593A5/de
Priority to IE2668/84A priority patent/IE57987B1/en
Priority to MT957A priority patent/MTP957B/xx
Priority claimed from MT957A external-priority patent/MTP957B/xx
Publication of JPS60193922A publication Critical patent/JPS60193922A/ja
Priority to SG310/88A priority patent/SG31088G/en
Publication of JPH0456804B2 publication Critical patent/JPH0456804B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59049321A 1983-10-17 1984-03-16 抗ウイルス剤 Granted JPS60193922A (ja)

Priority Applications (20)

Application Number Priority Date Filing Date Title
JP59049321A JPS60193922A (ja) 1984-03-16 1984-03-16 抗ウイルス剤
NZ209840A NZ209840A (en) 1983-10-17 1984-10-10 A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
GB08425799A GB2148302B (en) 1983-10-17 1984-10-12 Method for inhibiting viral propagation and anti-viral agent
AU34239/84A AU578625B2 (en) 1983-10-17 1984-10-15 Method for inhibiting propagation of virus and anti-viral agent
SE8405133A SE466482B (sv) 1983-10-17 1984-10-15 Med mrna hybridiserbart antiviralt medel
US06/661,204 US4689320A (en) 1983-10-17 1984-10-15 Method for inhibiting propagation of virus and anti-viral agent
LU85594A LU85594A1 (de) 1983-10-17 1984-10-15 Oligodeoxynucleotide und polydeoxynucleotide,die mit einem bereich einer bei der virusvermehrung synthetisierten mrna hybridisieren und ihre anwendung als therapeutische wirkstoffe
PH31340A PH21629A (en) 1983-10-17 1984-10-15 Method for inhibiting propagation of virus and anti-viral agent
AT0329284A AT392081B (de) 1983-10-17 1984-10-16 Verfahren zur herstellung eines arzneimittels zur behandlung von virusinfektionen
DK493584A DK168061B1 (da) 1983-10-17 1984-10-16 Med mrna hybridiserbart anti-viralt middel
NL8403163A NL8403163A (nl) 1983-10-17 1984-10-16 Werkwijze voor het remmen van virus voortplanting, en een anti-viraal agents.
BE0/213837A BE900827A (fr) 1983-10-17 1984-10-16 Procede pour inhiber la propagation de virus et agent antiviral.
DE19843437852 DE3437852A1 (de) 1983-10-17 1984-10-16 Oligodeoxynucleotide und polydeoxynucleotide, die mit einem bereich einer bei der virusvermehrung synthetisierten mrna hybridisieren und ihre anwendung als therapeutische wirkstoffe
IT68021/84A IT1179144B (it) 1983-10-17 1984-10-16 Agente anti virale e procedimento per inibire la propagazione di un virus
DZ847306A DZ691A1 (fr) 1983-10-17 1984-10-17 Nouveaux oligodésoxynucléotides et polydésoxynucléotides utiles.
FR8415930A FR2553420B1 (fr) 1983-10-17 1984-10-17 Nouveaux oligodesoxynucleotides et polydesoxynucleotides utiles comme agents antiviraux
CH4975/84A CH667593A5 (de) 1983-10-17 1984-10-17 Arzneimittel zur behandlung von virusinfektionen enthaltend oligodeoxynucleotide und/oder polydeoxynucleotide.
IE2668/84A IE57987B1 (en) 1983-10-17 1984-10-17 Method for inhibiting viral propagation and anti-viral agent
MT957A MTP957B (en) 1983-10-17 1984-12-12 Method for inhibiting viral propagation and anti-viral agent
SG310/88A SG31088G (en) 1983-10-17 1988-05-19 Method for inhibiting viral propagation and anti-viral agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59049321A JPS60193922A (ja) 1984-03-16 1984-03-16 抗ウイルス剤
MT957A MTP957B (en) 1983-10-17 1984-12-12 Method for inhibiting viral propagation and anti-viral agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP07540396A Division JP3328682B2 (ja) 1996-03-06 1996-03-06 ヘルペスウィルスの増殖阻害方法

Publications (2)

Publication Number Publication Date
JPS60193922A JPS60193922A (ja) 1985-10-02
JPH0456804B2 true JPH0456804B2 (da) 1992-09-09

Family

ID=26389704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59049321A Granted JPS60193922A (ja) 1983-10-17 1984-03-16 抗ウイルス剤

Country Status (1)

Country Link
JP (1) JPS60193922A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568254B1 (fr) * 1984-07-25 1988-04-29 Centre Nat Rech Scient Application d'oligonucleotides lies a un agent intercalant, notamment a titre de medicament

Also Published As

Publication number Publication date
JPS60193922A (ja) 1985-10-02

Similar Documents

Publication Publication Date Title
US4689320A (en) Method for inhibiting propagation of virus and anti-viral agent
KR970005274B1 (ko) 안티센스 올리고뉴클레오티드에 의한 a형 인플루엔자 바이러스, 안 아아보스트레인(ann arbor strain) h2n2의 억제
AU708535B2 (en) RNase L activators and antisense oligonucleotides effective to treat RSV infections
US6214805B1 (en) RNase L activators and antisense oligonucleotides effective to treat RSV infections
CA2081777A1 (en) Inhibition of influenza virus replication by oligonucleotides
JPH10510435A (ja) Ｂ型肝炎ウイルス複製のアンチセンス阻害
JPH11501509A (ja) ｔ（１４：１８）転座を有する腫瘍細胞に関連するアンチセンス転写産物とこの腫瘍細胞の診断及び治療に有用なオリゴデオキシヌクレオチド
IL217228A (en) Compounds of Type 2'-Deoxy-2'-Fluoro-2'-c-Methyluridine Nucleoside Phosphoramide Compounds
GB2273932A (en) Stable oligonucleotides
JP2010068809A (ja) Ｈｉｖ逆転写酵素により取り込まれ、そして不正確な塩基対合を引き起こすヌクレオシドアナログについてスクリーニングする方法
JP2012515165A (ja) 多臓器不全症候群（ｍｏｄｓ）の予防および／または処置のためのインターロイキン−２２の使用
CN118766918B (zh) m-AMSA或其衍生物在制备预防和/或治疗非洲猪瘟病毒感染的药物中的用途
JPH06505401A (ja) ウイルス、特に病原性レトロウイルスによって誘発される疾病の予防または治療のための形質転換された細胞
JPH04352724A (ja) 免疫調節型治療剤
JP3328682B2 (ja) ヘルペスウィルスの増殖阻害方法
JPS60193922A (ja) 抗ウイルス剤
CA2211877A1 (en) Human immunodeficiency virus transcription inhibitors and methods of their use
EP0960216A1 (en) Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
JPH0514684B2 (da)
WO1999028452A1 (en) Matrilysin antisense compounds
KR100285586B1 (ko) 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제
JPH09227384A (ja) 抗ｈｉｖ剤
JP2003527419A (ja) 抗ｈｉｖ活性を有する化合物
JPS58189197A (ja) 新規ｄｎａおよびその用途
KR100231318B1 (ko) 종양괴사인자 알파 수용체의 c-말단 부분을 갖는 레트로바이러스 벡터 및 이를 이용한 hiv-1 증식 억제 방법

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term